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Abstract In this study oxidation of low-density lipoprotein
(LDL) induced by different Cu2+ concentrations was investi-
gated. Lipid peroxidation was assessed by monitoring low-level
chemiluminescence (LL-CL), conjugated diene hydroperoxide
(CD) and K-tocopherol (TocOH), the major lipophilic antiox-
idant in LDL. At high Cu2+ concentration, LDL oxidation was
characterised by CD formation, LL-CL emission and TocOH
consumption. At low Cu2+ concentration, CD formation was
independent of LL-CL and occurred in the presence of TocOH.
Thus, two different mechanisms lead to lipid peroxide formation
in LDL. The combination of CD assay and LL-CL monitoring
makes it possible to distinguish the autocatalytic mechanism of
CD formation and that associated with TocOH, found at a high
and a low rate of initiation, respectively.
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1. Introduction
Several lines of evidence suggest that oxidation of low-den-
sity lipoprotein (LDL) may be involved in the early phase and
during progression of atherogenesis [1^3]. In general, the eval-
uation of LDL oxidation is fraught with di⁄culties [4]. Re-
cently, we reported that oxidation of isolated LDL was asso-
ciated with the emission of low-level chemiluminescence (LL-
CL), which is the basis of a new method to monitor oxidation
[5].
Although the basic principles of lipid peroxidation are rel-
atively simple and established, including an initiation, a prop-
agation and a termination phase [6^8], their application to
lipoproteins has raised a number of unresolved issues. One
of the most intriguing points is that the mechanism of LDL
oxidation may be in part di¡erent at low and high initiation
rates [9]. This may be the reason for the apparently ambigu-
ous role of K-tocopherol (TocOH), the most abundant lipo-
philic antioxidant in LDL. At ¢rst, it was taken for granted
that signi¢cant oxidation of polyunsaturated fatty acids to
lipid peroxides (LOOH) would occur only after the complete
consumption of TocOH [10]. However, subsequent studies
demonstrated that when su⁄ciently low concentrations of
Cu2 or peroxyl radicals were used, the oxidation of LDL
occurred also in the presence of endogenous TocOH [11^
13]. These observations led to the formulation of the Toc-
OH-mediated peroxidation model, according to which TocO
could attack a polyunsaturated fatty acid, contributing signi¢-
cantly to oxidation at low radical £ux, thus acting as a proox-
idant [11,12].
In our study LDL oxidation at various initiation rates was
monitored by LL-CL, conjugated diene (CD) hydroperoxides,
and TocOH. The relationships between these oxidation pa-
rameters are illustrated and two pathways leading to lipid
peroxides are proposed. The use of Cu2 as an oxidation
catalyst is justi¢ed because it is possibly involved in LDL
oxidation in vivo, as suggested by the observation that tran-
sition metal ions (mainly copper and iron) were found in
atherosclerotic lesion in free [14] and protein-bound form
[15] and the presence of metal ions (even as a contaminant)
is a prerequisite for cell-mediated LDL oxidation [16].
2. Materials and methods
2.1. Materials
All reagents were of AR grade and were obtained from either
Merck (Darmstadt, Germany) or Sigma (St. Louis, MO, USA).
2.2. Preparation of LDL
LDL was isolated from plasma of normolipidaemic healthy volun-
teers of both sexes (age 25^35 years) after an overnight fast by ultra-
centrifugation in a single-step discontinuous gradient [5]. LDL was
stored in a vial under argon at 4‡C in the dark and used within
1 week after preparation. Chemical composition of LDL was normal
according to Esterbauer and Ramos [6].
2.3. LDL oxidation
Before oxidation, LDL was freed of EDTA by gel ¢ltration [5].
LDL concentration was determined by total cholesterol assay
(CHOD-PAP kit, Boehringer Mannheim, Germany). Assuming a mo-
lecular mass of 2.5 MDa for LDL and a cholesterol content of 31%, a
concentration of 0.2 WM LDL corresponded to 0.5 mg/ml total mass
and 158 Wg/ml total cholesterol [17].
LDL, freed of EDTA, was oxidised with CuSO4 at various concen-
trations (0.2, 0.5 and 1.6 WM) in PBS at 37‡C [5]. In our incubation
mixtures biocides were not added because they might interfere with
LDL oxidation by several mechanisms, including free radical scaveng-
ing and metal binding activity. Several approaches were taken to
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prevent the growth of contaminating microorganisms in our oxidation
mixtures, which include the use of autoclaved materials (cuvettes,
pipettes), of ¢ltered PBS and LDL solutions (pore size 0.2 Wm). At
the end of the incubation time the incubation mixtures were clear and
UV-Vis spectra did not show evidence of Tyndall light scattering due
to microbial growth. Moreover, aliquots of LDL incubation mixtures
at the end of incubation were plated on various agar media and the
absence of microbial growth was observed.
2.4. Assessment of LDL oxidation
CD hydroperoxides were monitored by recording the increase of
absorbance at 234 nm (A234 nm) and estimated with a molar absorp-
tion coe⁄cient of 29 500 M31 cm31 [18]. As kinetic index of LDL
oxidation, lag time was determined graphically [17,18]; maximum rate
of oxidation was calculated as the highest value of the ¢rst derivative
of CD vs time pro¢le. TocOH was measured by HPLC chromatog-
raphy using a reverse-phase C18 column and spectrophotometric de-
tection at 292 nm; an external standard was used for calibration [19].
In our preparations, TocOH content of LDL was 5 þ 0.3 mol/mol
LDL.
2.5. Chemiluminescence measurement
LL-CL was measured in a Lucy 1 luminometer (Anthos Labtech
Instruments, Salzburg, Austria) equipped with a photon counting
photomultiplier (sensitivity ranging from 300 to 700 nm). Integration
time for each data point was set to 90 s. The assays were performed at
37‡C, in a white microplate. The source of LL-CL is the decay to
the ground state of triplet carbonyl compounds (LC = 3O) produced
by recombination of lipid peroxyl radicals to non-radical products
[5].
3. Results
The kinetic pro¢les of LDL oxidation were monitored at
di¡erent Cu2 concentrations by both CD and LL-CL. At
high Cu2 concentration (1.6 WM) (Fig. 1A,B), the kinetic
pro¢les exhibited an inhibited phase (lag time) which was
followed by a propagation phase characterised by the fast
increase of CD and LL-CL. The time courses of CD and
LL-CL were quite similar. The CD concentration at the end
of incubation was 58 þ 6 WM (about 290 mol CD/mol LDL);
the maximum rate of oxidation was reached 240 min after the
start of incubation and was 0.7 þ 0.06 WM CD/min.
With decreasing Cu2 concentration, the CD pro¢le showed
increasing complexity. At 0.5 WM Cu2 (Fig. 1C), it was S-
shaped and three phases could be distinguished: a preoxida-
tion phase (from 0 to about 150 min), a lag phase (from 150
to 400 min) and a propagation phase (from 400 to 600 min).
The maximum rate of oxidation was reached at 530 min of
Fig. 1. Kinetic pro¢le of LDL oxidation induced by Cu2. 0.2 WM LDL was incubated at 37‡C in PBS. Oxidation was monitored by recording
CD formation and LL-CL. Cu2 concentrations were 1.6 WM (A, B), 0.5 WM (C, D), 0.2 WM (E, F). The results are representative of four in-
dependent experiments.
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incubation and was 0.18 þ 0.01 WM CD/min. At the end of the
incubation, the CD concentration was similar to that found at
1.6 WM Cu2. The LL-CL pro¢le maintained the typical bi-
phasic shape, with an inhibited and a fast increase at 0.5 WM
Cu2 (Fig. 1D). Interestingly, the rise of LL-CL was associ-
ated with the propagation phase of CD but not with the
preoxidation phase, i.e. the initial formation of CD after
Cu2 addition.
At 0.2 WM Cu2, the CD formation exhibited an increase
after Cu2 addition and then it slowed down progressively
(Fig. 1E). The maximum rate of oxidation was reached at
70 min of incubation (much earlier than at 1.6 and 0.5 WM
Cu2) and was 0.12 þ 0.02 WM CD/min. At the end of incu-
bation, the CD concentration was 35 þ 4 WM (Fig. 1E), about
60% of the value found at higher Cu2 concentrations. For
0.2 WM Cu2, virtually no LL-CL could be detected (Fig. 1F).
Thus, with a decreasing rate of initiation, di¡erences between
CD and LL-CL pro¢les were found.
As a further index of oxidation, TocOH was assayed during
LDL oxidation at the di¡erent Cu2 concentrations used (Fig.
2). Complete consumption of TocOH was obtained after 120
min of incubation at 1.6 WM Cu2, thus before formation of
signi¢cant amounts of CD and LL-CL (Fig. 2 and see Fig.
1A,B). TocOH was consumed at about 380 min at 0.5 WM
Cu2, after concomitant formation of CD during preoxida-
tion and lag phase (about 17 WM, i.e. 85 mol CD/mol LDL)
(Fig. 2 and see Fig. 1C) but before the rise of LL-CL (see Fig.
1D). At 0.2 WM Cu2, TocOH was still present at the end of
the incubation at a concentration of 2 mol/mol LDL (Fig. 2).
These data indicate that at lower rates of initiation lipid
peroxides were formed in the presence of lipophilic antioxi-
dants.
4. Discussion
Our results show direct evidence that the mechanism of
LDL oxidation changes depending on Cu2 concentration,
which is a major determinant of the initiation rate of lipid
peroxidation. The modi¢cations of CD time course with de-
creasing Cu2 concentration are in substantial agreement with
previous ¢ndings [9,13], although it was not generally agreed
that this could have any mechanistic bearing. The monitoring
of oxidation by LL-CL provides new insights into this issue,
following the consideration that the source of LL-CL is the
termination reaction between two peroxyl radicals, LOO
[5,20,21] :
LOO  LOO ! LOH LCx3O 3O2 1
where 3O2 and LCx3O indicate triplet oxygen and triplet
carbonyl compounds, respectively.
At high Cu2 concentration (1.6 WM), LL-CL and CD pro-
¢les were essentially parallel and oxidation occurred through
the main propagating reaction:
LOO  LHO2 ! LOOH LOO 2
where LH indicates the reactive methylene group of a poly-
unsaturated fatty acid. This reaction ensues after depletion of
TocOH by initiating radicals during lag phase and yields a
high concentration of lipid peroxyl radicals, which can be
detected by LL-CL. This model interprets lipid peroxidation
in LDL at high Cu2 concentrations as a free radical-medi-
ated autocatalytic reaction, in agreement with conventional
knowledge [6,8]. As lipid peroxidation proceeds, various
breakdown products of lipid peroxides (including biologically
active aldehydes) are formed which covalently modify apo B-
100, increasing the a⁄nity of LDL for macrophage scavenger
receptor [2,6].
The formation of lipid peroxides at low radical £ux in the
presence of TocOH and the absence of LL-CL can be ex-
plained by a di¡erent model, which takes into account the
chemical reactivity of TocOH [7] and in particular its ability
to scavenge lipid peroxyl radical and the possibility that it
may attack a polyunsaturated fatty acid, acting as a chain
transfer agent and being regenerated, as ¢rst described by
Bowry and Stocker [11]:
TocOH LOO ! LOOH TocO 3
TocO  LH! L  TocOH 4
L O2 ! LOO 5
As shown by our measurements, the cycle proposed does not
generate LL-CL, because the high a⁄nity of TocOH for
LOO prevents reaction 1.
Our study implies an intriguing function for TocOH. The
argument that TocOH acts as antioxidant at high rate of
initiation is widely accepted [6^13] and is in agreement with
our ¢ndings. The role of TocOH in LDL oxidation at low
Cu2 appears more problematic. In a number of studies [11^
13] an exclusively prooxidant role was ascribed to TocOH,
when LDL oxidation was induced at low radical £ux. Alter-
natively, on the basis of our results, TocOH may be involved
in a set of reactions which have an antioxidant (Eq. 3) as well
as a prooxidant e¡ect (Eq. 4), as already proposed in a mech-
anistic study [22]. The result of this balanced mechanism is a
slow formation of lipid peroxides without emission of LL-CL,
explaining the low amount of lipid peroxides formed at the
lowest Cu2 concentration employed.
Hence, LL-CL makes it possible to distinguish the forma-
tion of lipid peroxides in LDL via the autocatalytic, propa-
gative mechanism from that via a TocOH-regenerating mech-
anism, which are typical of a high and a low rate of initiation,
respectively.
Fig. 2. Time course of TocOH consumption during LDL oxidation.
0.2 WM LDL was incubated at 37‡C in PBS; Cu2 concentrations
were 1.6 WM (O), 0.5 WM (E), and 0.2 WM (7). Appropriate ali-
quots of the oxidation mixture were withdrawn at the time points
indicated and the reaction was stopped by addition of EDTA solu-
tion (1 mg/ml, ¢nal).
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If our results are extrapolated to the physiological situation,
the LDL oxidation pathway occurring at low radical £ux
might be particularly insidious because lipophilic antioxi-
dants, such as TocOH, might not prevent the formation of
lipid peroxides. Through this mechanism, LDL might be
‘seeded’ with lipid peroxides and become highly susceptible
to the conventional autocatalytic peroxidation. This sequence
of events might explain how LDL is oxidised in interstitial
£uid of arterial wall, which contains a high concentration of
plasma antioxidants. The evidence that even minute amounts
of Cu2 are able to oxidise LDL suggests the possible proox-
idant role of transition metals, which may be released from
damaged plasma transport protein and cellular debris in ath-
erosclerotic lesion [8]. On the basis of the present knowledge,
it is not possible to estimate the level of oxidative stress which
LDL undergoes in arterial wall ; however, it is conceivable
that both the autocatalytic mechanism of LDL oxidation
and that associated with TocOH may be e¡ective in vivo, as
suggested by ¢ndings that both heavily [23] and mildly [24]
oxidised LDL are present in arterial wall.
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